Kwality Pharmaceuticals Limited (KPL) — Stock Analysis

Kwality Pharmaceuticals Limited (NSE: KPL), ISIN INE552U01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

KPL last traded at ₹2603.05 (+0.53%), with a 52-week range of ₹828.80 to ₹2889.00 (as of 30 Jul 2026).

Shareholding as of Dec 2025: promoters 54.83%, FIIs 0.50%, DIIs 0.33%, mutual funds 0.00%.

EquiSense Score (ECS): 77/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.